[Federal Register Volume 83, Number 181 (Tuesday, September 18, 2018)]
[Notices]
[Page 47180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC)/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment (CHACHSPT) has scheduled a public meeting. Information about 
the CHACHSPT can be found here: https://www.cdc.gov/maso/facm/facmchachspt.html. An agenda may be requested by emailing 
[email protected].

DATES: November 7, 2018, 8:30 a.m.-5:00 p.m. ET and November 8, 2018, 
8:30 a.m.-3:30 p.m. ET.

ADDRESSES: This meeting will be held in-person and by webinar and 
teleconference. The address for the meeting is DoubleTree by Hilton, 
Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland 20814.
     Adobe Connect URL link: https://hrsa.connectsolutions.com/chac_meeting/.
     Conference call-in number: 888-324-9617, Passcode 9245865.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Chief, Policy 
Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and 
Data, 5600 Fishers Lane, Room 9N156, or by email at 
[email protected].

SUPPLEMENTARY INFORMATION: The CHACHSPT was established under Section 
222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], 
as amended.
    The purpose of the CHACHSPT is to advise the Secretary of HHS, the 
Director of the CDC, and the Administrator of HRSA on the objectives, 
strategies, policies, and priorities for HIV, viral hepatitis, and 
other STD prevention and treatment efforts. This includes, but is not 
limited to, surveillance of HIV infection, viral hepatitis, and other 
STDs; responses to related emerging health needs; and epidemiologic, 
behavioral, health services, and laboratory research on HIV/AIDS, viral 
hepatitis, and other STDs. The CHACHSPT also provides advice regarding 
policy issues related to HIV/viral hepatitis/STD professional 
education, patient healthcare delivery, research and training, and 
prevention services.
    During the November 7-8, 2018, meeting, the CHACHSPT will discuss 
the following topics:
     CHACHSPT workgroup reports and findings;
     updates from CDC, HRSA, and HRSA HAB;
     strategies for serving women, infants, children, and 
youth;
     agencies' responses to the opioid crisis; and
     telemedicine initiatives.

Agenda items are subject to change as priorities dictate. Refer to the 
CHACHSPT website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHACHSPT should be 
sent by email to [email protected] or by mail to Theresa 
Jumento at the address above at least 3 business days prior to the 
meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Theresa Jumento at the 
address listed above at least 10 business days prior to the meeting.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-20269 Filed 9-17-18; 8:45 am]
BILLING CODE 4165-15-P